Oncology & Cancer
Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma
A new research paper was published in Oncotarget entitled, "Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma."
Jul 26, 2024
0
0
Melanoma
Oncology & Cancer
Taking a closer look at eye cancer: Research offers new insight into high rate of metastasis
New research from Edith Cowan University (ECU) is one step closer to understanding why uveal melanoma, the deadliest form of eye cancer, has such a high rate of metastasis.
Jul 22, 2024
0
107
Oncology & Cancer
Immunotherapy approach shows potential in some people with metastatic solid tumors
Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from the National Institutes of Health ...
Jul 11, 2024
0
32
Oncology & Cancer
First-of-its-kind clinical trial eliminates or shrinks melanoma tumors in 70% of patients
A clinical trial has shown that a new drug combination utilized before surgery completely eliminated or shrunk melanoma tumors in 70% of trial participants. The phase II clinical trial, NeoACTIVATE, enrolled patients with ...
Jul 11, 2024
0
54
Immunology
Ointment containing DNA molecules can combat allergic contact dermatitis
Researchers at the University of Bonn have isolated a DNA molecule that is suitable for combating allergic contact dermatitis in mice. The aptamer binds to certain immune system messenger substances, rendering them ineffective. ...
Jul 5, 2024
0
29
Oncology & Cancer
High fail rate for melanoma self-checks increasing cancer risk, new study finds
Australians are unable to recognize malignant melanomas on their own skin, calling into question the effectiveness of national self-detection guidelines, according to new Southern Cross University research.
Jul 3, 2024
0
0
Oncology & Cancer
Understanding the mechanism behind melanoma resistance to treatment
In many cases of malignant melanoma, the effect of targeted treatment is lost over time. A research team from UZH and USZ has now discovered that a factor secreted by tumor cells is responsible for the resistance. These findings ...
Jun 27, 2024
0
19
Medications
Nonsignificant survival benefit seen for dabrafenib, trametinib in melanoma
For patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall survival, according to a study published in the New England Journal ...
Jun 24, 2024
0
0
Oncology & Cancer
Doing a skin check? Confidence is key and social media ads may help
It's summer and time to enjoy the sunshine. But it's also important to do so safely. Skin cancer is the most common form of cancer in the United States—and it's most commonly caused by sun exposure. Research has shown that ...
Jun 24, 2024
0
0
Oncology & Cancer
When does a melanoma metastasize? Implications for management
A new research perspective titled "When does a melanoma metastasize? Implications for management" has been published in Oncotarget.
Jun 18, 2024
0
0
